Relating to genetic information security for residents of this state; providing a civil penalty; providing a private cause of action.
Government Affairs & Regulatory Compliance Analysis
HB 130: Government Affairs Overview
The Texas Genomic Act of 2025 (HB130) mandates the immediate removal of genomic sequencing hardware and software originating from foreign adversaries (e. g. , China, Russia) and imposes strict data localization requirements.
1Vendor Procurement: New purchase agreements for lab equipment must include warranties of origin and ownership structure to ensure manufacturers are not owned or controlled by prohibited entities.
2M&A/Bankruptcy: Asset purchase agreements must disclose restrictions on selling genomic data to foreign entities.
Estimated Cost Impact
highSignificant operational investment may be required.
JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.
Need Help Navigating This Legislation?
JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.
HB130
Relating to genetic information security for residents of this state; providing a civil penalty; providing a private cause of action.
Critical Urgency
Unanimous Passage
House Vote141 - 0
YEA
100% in favor141 voting
Senate Vote31 - 0
YEA
100% in favor31 voting
Cost Impact
High
Effective
2025-06-20
Enforcing Agencies
Office of the Attorney General
Primary Author: Rep. Greg Bonnen
89th Texas Legislature
jdkey.com
01
Compliance Analysis
Key implementation requirements and action items for compliance with this legislation
Implementation Timeline
Effective Date: June 20, 2025 (Immediate effect due to supermajority passage).
Compliance Deadline:Immediate for hardware prohibitions and data storage restrictions. December 31, 2025, is the deadline for the first annual certification filing.
Agency Rulemaking: The Office of the Attorney General (OAG) is expected to publish the specific form/portal for the annual certification. Until then, entities must operate under the assumption of strict statutory interpretation regarding "inaccessible" data.
Immediate Action Plan
Immediate Inventory Audit: Identify all genome sequencers and software. Cross-reference manufacturers against the 15 C.F.R. 791.4 Foreign Adversary list (specifically check for BGI/MGI equipment).
Decommission Prohibited Tech: Cease use of any identified prohibited hardware immediately to avoid daily penalties.
Retain Counsel: Secure an attorney specifically to review your compliance status and sign the December 31 certification.
Geofence Data: Instruct IT to implement blocks on all traffic to/from prohibited nations regarding genomic data servers.
Operational Changes Required
Contracts
Cloud & Storage MSAs: Must be amended to explicitly guarantee that Texas resident genomic data is never stored in, or accessible from, a "Foreign Adversary" nation (currently China, Russia, Iran, North Korea).
Vendor Procurement: New purchase agreements for lab equipment must include warranties of origin and ownership structure to ensure manufacturers are not owned or controlled by prohibited entities.
M&A/Bankruptcy: Asset purchase agreements must disclose restrictions on selling genomic data to foreign entities.
Hiring/Training
Legal Designation: Unlike standard compliance reports, the annual certification must be submitted by an attorney. You must engage outside counsel or formally designate an in-house attorney to assume this specific liability.
IT Security: IT staff require immediate training on implementing strict IP blocking and Access Control Lists (ACLs) to geofence data from prohibited jurisdictions.
Reporting & Record-Keeping
Annual Certification: A mandatory filing to the OAG by December 31 each year, certifying compliance with Chapter 174.
Hardware Audit Trail: Maintain a permanent log of country-of-origin and ownership for all sequencers and sequencing software.
Data Residency Verification: Documentation proving physical server locations for all cloud-stored genomic data.
Fees & Costs
"Rip and Replace" Costs: High capital expenditure risk. There is no grandfather clause; prohibited equipment owned prior to the effective date must be decommissioned.
Litigation Reserves: The law creates a private cause of action with $5,000 statutory damages per violation, creating immediate class-action exposure.
Civil Penalties: $10,000 per violation payable to the State.
Strategic Ambiguities & Considerations
"Inaccessible": The statute requires data be inaccessible to persons in prohibited countries. It is unclear if incidental internet routing constitutes a violation. Strategy: Assume a strict standard; logical and physical access must be affirmatively blocked.
"Resident of this State": The law lacks a verification mechanism for residency. Strategy: If you process de-identified data or biobank samples, treat *all* data as subject to the Act unless you can affirmatively prove the subject is a non-resident.
"Related Equipment": The definition of software includes "related equipment," which may extend to firmware on peripheral devices.
Need Compliance Guidance on This Legislation?
JD Key Consulting specializes in Texas regulatory compliance strategy. Work directly with James Dickey—former Chairman of the Republican Party of Texas—to understand this bill's impact on your operations and develop an actionable compliance plan.
Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.
The Texas Genomic Act of 2025 (HB130) mandates the immediate removal of genomic sequencing hardware and software originating from foreign adversaries (e. g. , China, Russia) and imposes strict data localization requirements.
Q
Who authored HB130?
HB130 was authored by Texas Representative Greg Bonnen during the Regular Session.
Q
When was HB130 signed into law?
HB130 was signed into law by Governor Greg Abbott on June 20, 2025.
Q
Which agencies enforce HB130?
HB130 is enforced by Office of the Attorney General.
Q
How significant are the changes in HB130?
The regulatory priority for HB130 is rated as "critical". Businesses and organizations should review the legislation to understand potential impacts.
Q
What is the cost impact of HB130?
The cost impact of HB130 is estimated as "high". This may vary based on industry and implementation requirements.
Q
What topics does HB130 address?
HB130 addresses topics including health, health--general, health--other diseases & medical conditions, intergovernmental relations and charitable & nonprofit organizations.
Q
What are the key dates for HB130?
Key dates for HB130: Effective date is 2025-06-20. Consult with legal counsel regarding applicability.
Q
What are the penalties under HB130?
HB130 establishes the following penalties: civil penalty of $10,000 per violation for Violation of equipment prohibitions, data storage restrictions, or reporting requirements (payable to State); civil penalty of Greater of actual damages or $5,000 statutory damages per violation for Private cause of action for residents harmed by unauthorized storage or use of genome data. Consult with legal counsel for specific applicability to your situation.
Q
Which Texas businesses are affected by HB130?
HB130 primarily affects healthcare providers and medical facilities. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.
Need Strategic Guidance on This Legislation?
JD Key Consulting is an Austin, Texas-based government affairs firm led by James Dickey, former Chairman of the Republican Party of Texas. We specialize in Texas regulatory compliance and legislative strategy for data centers, energy, banking, and manufacturing.